NEUROSTAR 81-02315-000

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-05-29 for NEUROSTAR 81-02315-000 manufactured by Neuronetics Inc..

Event Text Entries

[146400891] I had transcranial magnetic stimulation treatment (tms neurostar) for depression. It did not help with the depression (which was moderate) but caused debilitating anxiety that caused me to be almost non-functional and i was hospitalized. I had 36 tms treatments (all to left side of head), about half way through i descended into a severe depression, but that only lasted a few days, and i was advised to continue the treatment. The treatment was administered by a nonprofessional medical office mgr and even the supervising psychiatrist didn't seem to have much knowledge about the potential negative side effects of tms. Outcome attributed to adverse event: suicidal.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5086963
MDR Report Key8650831
Date Received2019-05-29
Date of Report2019-05-21
Date of Event2019-05-05
Date Added to Maude2019-05-29
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNEUROSTAR
Generic NameTRANSCRANIAL MAGNETIC STIMULATOR
Product CodeOBP
Date Received2019-05-29
Model Number81-02315-000
Device AvailabilityN
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerNEURONETICS INC.


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Life Threatening; 3. Deathisabilit 2019-05-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.